Aslan Pharmaceuticals Ltd ADR (ASLN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ASLN | AMGN | GILD | VRTX | REGN |
| Company | Aslan Pharmaceuticals Ltd ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.4700 | 270.63 | 66.58 | 404.50 | 906.90 |
| High | 0.4986 | 274.86 | 67.18 | 406.83 | 915.70 |
| Low | 0.4501 | 269.64 | 66.36 | 399.29 | 904.41 |
| Last | 0.4700 | 273.01 | 67.08 | 400.76 | 906.54 |
| Change | +0.0010 | -0.53 | +0.05 | -4.15 | -0.78 |
| % Change | +0.21% | -0.19% | +0.07% | -1.02% | -0.09% |
| Volume | 1,035,300 | 2,467,100 | 8,467,000 | 806,400 | 373,700 |
| 20-Day Average Volume | 889,575 | 2,172,705 | 6,490,535 | 970,000 | 441,820 |
| Previous Close | 0.4690 | 273.54 | 67.03 | 404.91 | 907.32 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.5311 | 271.55 | 69.07 | 403.29 | 926.29 |
| 20-Day Raw Stochastic | 18.18% | 44.22% | 14.81% | 32.03% | 18.66% |
| 20-Day Relative Strength | 44.83% | 48.18% | 33.12% | 44.82% | 39.46% |
| Weighted Alpha | -91.00 | +11.15 | -20.78 | +16.09 | +13.86 |
| Today's Opinion | 88% Sell | 40% Sell | 100% Sell | 8% Buy | 24% Buy |
| Previous Opinion | 88% Sell | 40% Sell | 100% Sell | 24% Buy | 24% Buy |
| Last Month's Opinion | 40% Sell | 24% Buy | 88% Sell | 40% Buy | 80% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -4.28% since 04/17/24 | +3.39% since 04/17/24 | +0.22% since 04/17/24 | +1.95% since 04/17/24 | +0.59% since 04/17/24 |
| Low | 0.4300 on 04/22/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 391.01 on 04/18/24 | 891.46 on 04/19/24 |
| High | 0.6121 on 04/22/24 | 274.86 on 04/24/24 | 67.68 on 04/23/24 | 406.86 on 04/23/24 | 920.73 on 04/19/24 |
| 1-Month | |||||
| %Chg | -28.02% since 03/22/24 | -1.14% since 03/22/24 | -7.62% since 03/22/24 | -3.58% since 03/22/24 | -6.28% since 03/22/24 |
| Low | 0.4300 on 04/22/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 391.01 on 04/18/24 | 890.43 on 04/16/24 |
| High | 0.6875 on 03/25/24 | 288.57 on 03/28/24 | 73.87 on 03/28/24 | 421.45 on 04/01/24 | 976.75 on 03/27/24 |
| 3-Month | |||||
| %Chg | -10.44% since 01/24/24 | -10.64% since 01/24/24 | -15.65% since 01/24/24 | -6.27% since 01/24/24 | -4.40% since 01/24/24 |
| Low | 0.4000 on 02/22/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 391.01 on 04/18/24 | 890.43 on 04/16/24 |
| High | 2.0900 on 03/12/24 | 329.72 on 02/05/24 | 81.06 on 01/25/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 |
| 6-Month | |||||
| %Chg | -60.83% since 10/24/23 | -1.13% since 10/24/23 | -14.17% since 10/24/23 | +8.50% since 10/24/23 | +12.71% since 10/24/23 |
| Low | 0.3920 on 12/26/23 | 249.70 on 10/31/23 | 65.90 on 04/18/24 | 341.90 on 11/16/23 | 769.19 on 10/27/23 |
| High | 2.0900 on 03/12/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 7,685 | 146,436,016 | 83,519,768 | 103,580,040 | 99,503,640 |
| Shares Outstanding, K | 16,350 | 536,376 | 1,245,077 | 258,459 | 109,762 |
| Annual Sales | 12,000,000 | 28,190,000,000 | 27,116,000,000 | 9,869,200,000 | 13,117,200,000 |
| Annual Net Income | -44,220,000 | 6,717,000,000 | 5,665,000,000 | 3,619,600,000 | 3,953,600,000 |
| Last Quarter Sales | 0 | 8,196,000,000 | 7,114,000,000 | 2,517,700,000 | 3,434,300,000 |
| Last Quarter Net Income | -9,710,000 | 767,000,000 | 1,429,000,000 | 968,800,000 | 1,159,600,000 |
| 60-Month Beta | 1.45 | 0.58 | 0.19 | 0.35 | 0.11 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.78 on 04/12/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 4.20 on 02/05/24 | 11.86 on 02/02/24 |
| Latest Earnings Date | 04/26/24 | 05/02/24 | 04/25/24 | 05/06/24 | 05/02/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 03/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.67 | 9.97 | 30.13 | 24.14 |